Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

Original Publication: Oxford, UK : Avenel, N.J. : Oxford University Press ; Distributed by Mercury International, c1999-

Disability Evaluation* ; Health Status* ; Quality of Life*; Arthritis, Juvenile/*complications ; Depression/*diagnosis ; Disabled Persons/*rehabilitation; Adolescent ; Arthritis, Juvenile/diagnosis ; Arthritis, Juvenile/rehabilitation ; Child ; Cross-Sectional Studies ; Depression/etiology ; Depression/rehabilitation ; Female ; Follow-Up Studies ; Humans ; Male ; Prospective Studies ; Severity of Illness Index ; Surveys and Questionnaires ; Time Factors

Objectives: To determine if depressive symptoms assessed near diagnosis associate with future measures of pain, disability and disease for adolescent patients diagnosed with JIA.
Methods: Data were analysed from JIA patients aged 11-16 years recruited to the Childhood Arthritis Prospective Study, a UK-based inception cohort of childhood-onset arthritis. Depressive symptoms (using the Mood and Feelings Questionnaire; MFQ), active and limited joint count, disability score (Childhood Health Assessment Questionnaire), pain visual analogue scale and patient's general evaluation visual analogue scale were collected. Associations between baseline measures (first visit to paediatric rheumatologist) were analysed using multiple linear regression. Linear mixed-effect models for change in the clinical measures of disease over 48 months were estimated including MFQ as an explanatory variable.
Results: Data from 102 patients were analysed. At baseline, median (IQR) age was 13.2 years (11.9-14.2 years) and 14.7% scored over the MFQ cut-off for major depressive disorder. At baseline, depressive symptoms significantly associated with all clinical measures of disease (P ⩽ 0.01). High baseline depressive symptoms scores predicted worse pain (P ⩽ 0.005) and disability (P ⩽ 0.001) 12 months later but not active and limited joint counts.
Conclusions: Adolescent patients with JIA and depressive symptoms had more active joints, pain and disability at the time of their first specialist appointment. The associations between baseline depression and both pain and disability continued for at least one year, however, this was not the case for active joint count.

Rheumatology (Oxford). 2016 Feb;55(2):268-78. (PMID: 26350486)
Med Hypotheses. 1991 Aug;35(4):298-306. (PMID: 1943879)
Nat Rev Rheumatol. 2014 Mar;10(3):187-93. (PMID: 24394351)
Int J Neuropsychopharmacol. 2015 Jan 20;18(8):null. (PMID: 25603858)
Eur Psychiatry. 2005 May;20(3):274-6. (PMID: 15935428)
BMJ. 2005 Feb 5;330(7486):301-4. (PMID: 15695279)
J Psychosom Res. 2001 Dec;51(6):713-9. (PMID: 11750293)
J Am Acad Child Adolesc Psychiatry. 2003 Oct;42(10):1203-11. (PMID: 14560170)
JAMA Psychiatry. 2013 Jan;70(1):31-41. (PMID: 22945416)
J Child Psychol Psychiatry. 1995 Feb;36(2):327-34. (PMID: 7759594)
J Pediatr Psychol. 2006 Nov-Dec;31(10):1046-56. (PMID: 16150876)
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):296-312. (PMID: 16492261)
Arthritis Rheum. 2005 Apr 15;53(2):178-84. (PMID: 15818646)
J Affect Disord. 2004 Mar;78(3):273-7. (PMID: 15013254)
Clin J Pain. 2013 Aug;29(8):681-8. (PMID: 23370064)
Psychol Bull. 1994 May;115(3):424-43. (PMID: 8016286)
Psychoneuroendocrinology. 2015 Jan;51:164-75. (PMID: 25462890)
J Child Psychol Psychiatry. 1997 Jul;38(5):565-73. (PMID: 9255700)
Clin Exp Rheumatol. 2014 Nov-Dec;32(6):904-13. (PMID: 25190569)
J Rheumatol. 1996 Nov;23(11):1975-80. (PMID: 8923378)
Curr Opin Rheumatol. 2010 Mar;22(2):213-7. (PMID: 20010296)
Psychosom Med. 1998 May-Jun;60(3):283-9. (PMID: 9625215)
Psychoneuroendocrinology. 2007 Jun;32(5):516-31. (PMID: 17482371)
J Rheumatol. 2014 Feb;41(2):345-51. (PMID: 24334648)
Biol Psychiatry. 2010 Mar 1;67(5):446-57. (PMID: 20015486)
Rheumatology (Oxford). 2008 May;47(5):660-4. (PMID: 18356173)
Rheumatol Int. 2013 Aug;33(8):2045-52. (PMID: 23392772)
Br J Rheumatol. 1997 Dec;36(12):1304-11. (PMID: 9448592)
J Rheumatol. 2004 Feb;31(2):390-2. (PMID: 14760812)
Psychol Med. 1992 Feb;22(1):45-53. (PMID: 1574566)
J Pediatr Psychol. 1994 Apr;19(2):205-22. (PMID: 8051603)
Clin Rheumatol. 2011 Nov;30(11):1415-20. (PMID: 21887489)
J Affect Disord. 2012 Dec 20;143(1-3):34-8. (PMID: 22840610)
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5995-9. (PMID: 22474371)
Rheumatology (Oxford). 2002 Dec;41(12):1444-9. (PMID: 12468828)
Arthritis Rheum. 2002 Sep;46(9):2392-401. (PMID: 12355487)
Patient Prefer Adherence. 2014 Mar 17;8:323-30. (PMID: 24669189)
Clin Rheumatol. 2014 Mar;33(3):403-7. (PMID: 24108504)
J Behav Med. 1997 Oct;20(5):489-504. (PMID: 9415858)
Br J Hosp Med (Lond). 2012 Oct;73(10):564-70. (PMID: 23124286)
Br J Rheumatol. 1994 Aug;33(8):754-60. (PMID: 8055203)
Arch Intern Med. 2003 Nov 10;163(20):2433-45. (PMID: 14609780)
J Rheumatol. 2005 Feb;32(2):354-61. (PMID: 15693099)
Rheumatology (Oxford). 2008 Jul;47(7):991-5. (PMID: 18417527)

20542 United Kingdom ARC_ Arthritis Research UK; 20542 United Kingdom VAC_ Versus Arthritis; 20385 United Kingdom ARC_ Arthritis Research UK; MR/R013926/1 United Kingdom MRC_ Medical Research Council; MR/M004600/1 United Kingdom MRC_ Medical Research Council; 20164 United Kingdom ARC_ Arthritis Research UK

Date Created: 20180427 Date Completed: 20180810 Latest Revision: 20210109

20240513

PMC6055569

10.1093/rheumatology/key088

29697850